Follow the 신일제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신일제약 has published 54 insider filings. The latest transaction was reported on 4 June 2026 (Sale). Among the most active insiders: 홍성소. Every trade is accessible without an account.
54
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.